Replies to post #128073 on Anavex Life Sciences Corp (AVXL)

[Mikesc]

Welcome back... CTAD Anavex will present data to support the first precision approach to a PH 2/3 trial for a drug that is targeting the possible causes of AD.

I wonder what the reaction will be?